Propolis antimicrobial activity: What's new?;Attività antimicrobica della propoli: Cosa c'è di nuovo?

Infezioni in Medicina

Volumn 15, Issue 1, 2007, Pages 7-15

  De Vecchi, Elena ^a   Drago, Lorenzo ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Antimicrobial activity; Propolis; Respiratory pathogens

Indexed keywords

ANTIBIOTIC AGENT; BALSAM; CAFFEIC ACID; COUMARIC ACID; ESSENTIAL OIL; ESTER; FERULIC ACID; FLAVONOID; MINERAL; PROPOLIS; RESIN; TERPENE; VITAMIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; DRUG ACTIVITY; HEALING; HUMAN; LIVER PROTECTION; NONHUMAN; POLLEN; RESPIRATORY TRACT INFECTION; REVIEW;

ANTI-INFECTIVE AGENTS; BACTERIA; CANDIDA ALBICANS; DRUG RESISTANCE; HUMANS; MEDICINE, TRADITIONAL; MICROBIAL SENSITIVITY TESTS; PROPOLIS; RESPIRATORY TRACT INFECTIONS; STOMATITIS; VIRUSES;

EID: 34248562260     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (76)

1. Ghisalberti E.L. Propolis: a review. Bee Wld. 60, 59-84, 1978.
2. Bankova V.S., De Castro S.L., Marcucci M.C. Propolis: recent advances in chemistry and plant origin. Apidologie 31, 3-15, 2000.
3. Bankova V. Recent trends and important developments in propolis research. eCAM. 2, 29-32, 2005.
4. Banskota A.H., Tezuka Y., Kadota S. Recent progress in pharmacological research of propolis. Phytother. Res. 15, 561-571, 2001.
5. Burdock G.A. Review of the biological properties and toxicity of bee propolis (propolis). Food Chem. Toxicol. 36, 347-363, 1998.
6. Castaldo S., Capasso F. Propolis an old remedy used in modern medicine. Fitoterapia. 73 (Suppl.1), S1-S6, 2002.
7. Lindenfelser L.A. Antimicrobial activity of propolis. Am. Bee J. 107, 90-92, 1967.
8. Bankova V. Chemical diversity of propolis and the problem of standardization. J. Ethnopharmacol. 100, 114-117, 2005.
9. Silici S., Kutluca S. chemical composition and antibacterial activity of propolis collected by three different races of honeybees in the same region. J. Ethopharmacol. 99, 69-73, 2005.
10. Salatino A., Weinstein Teixeira E., Negri G., Message D. Origin and chemical variation of brazilian propolis. eCAM. 2, 33-38, 2005.
11. Marcucci M.C. Propolis: chemical composition, biological properties and therapeutic activity. Apidologie 26, 83-99, 1995.
12. Christov R., Bankova V., Hegazi A., Abd El Hady F., Popov S. Chemical composition of Egyptian propolis. Z. Naturforsch. 53, 197-200, 1998.
13. Marcucci M.C., Rodriguez J., Ferreres F., Bankova V., Groto R., Popov S. Chemical composition of Brazilian propolis from Sao Paulio State. Z. Naturforsch. 53, 117-119, 1998.
14. Martos I., Cossentini M., Ferreres F., Tomas-Barberan F.A. Flavonoid composition of tunisian honeys and propolis. J. Agric. Food Chem. 45, 2824-2829, 1997.
15. Park Y.K., Alencar S.M., Aguiar C.L. Botanical origin and chemical composition of brazilian propolis. J. Agric. Food Chem. 50, 2502-2506, 2002.
16. Martos I., Ferreres F., Yao L., D'Arcy B., Caffin N., Tomas-Barberan F.A. Flavonoids in monospecific eucalyptus honeys from Australia. J. Agric. Food Chem. 48, 4744-4748, 2000.
17. Piccinelli A.L., Campo Fernandez M., Cuesta-Rubio O., Marquez Hernandez I., De Simone F., Rastrelli L. Isoflavonoids isolated from Cuban propolis. J. Agric. Food Chem. 53, 9010-9016, 2005.
18. Cuesta-Rubio O., Frontana-Uribe B.A., Ramirez-Apan T., Cardenas J. Polyisoprenylated benzophenones in cuban propolis; biological activity of nemorosone. Z. Naturforsch. [C]. 57, 372-378, 2002.
19. Sforcin J.M., Orsi R.O., Bankova V. Effect of propolis, some isolated compounds and its source plant on antibody production. J. Ethnopharmacol. 98, 301-305, 2005.
20. Kujumgev A., Tsvetkova I., Serkedjieva Y., Bankova V., Christov R., Popov S. Antibacterial, antifungal and antiviral activity of propolis of different geographic origin. J. Ethnopharmacol. 64. 235-240, 1999.
21. Krol W., Scheller S., Shani J., Pietsz G., Czuba Z. Synergistic effect of ethanolic extract of propolis and antibiotics on the growth of Staphylococcus aureus. Arzneimittel-Forsch. 43, 607-609, 1993.
22. Sforcin J.M., Fandes A. Jr., Lopes C.A., Bankova V., Funari S.R. Seasonal effect on Brazilian propolis antibacterial activity. J. Ethnopharmacol. 73, 243-249, 2000.
23. Takaisi-Kikuni N.B., Schilcher H. Electron microscopy and microcalorimetric investigations of the possible mechanism of the antibacterial action of a defined propolis provenience. Planta Medica. 60, 222-227, 1994.
24. Cushnie T.P., Lamb A.J. Antimicrobial activity of flavonoids. Int. J. Antimicrob. Agents. 26, 343-356, 2005.
25. Cushnie T.P., Lamb A.J. Detection of galangin-induced cytoplasmic membrane damage in Staphylococcus aureus by measuring potassium loss. J. Ethnopharmacol. 101, 243-248, 2005.
26. Mirzoeva O.K., Grishanin R.N., Calder P.C. Antimicrobial action of propolis and some of its components: the effect on growth, membrane potential and motility of bacteria. Microbial Res. 152, 239-246, 1997.
27. Scazzocchio F., D'Auria F.D., Alessandrini D., Pantanella F. Multifactorial aspects of antimicrobial activity of propolis. Microbiol. Res. 161, 327-333, 2006.
28. D'Auria F.D., Tecca M., Scazzocchio F., Renzini V., Strippoli V. Effect of propolis on virulence factors of Candida albicans. J. Chemother. 15, 454-60, 2003.
29. Huleihel M., Isanti V. Anti-Herpes simplex virus effect of an aqueous extract of propolis. IMAJ. 4 (Suppl), 923-927, 2002.
30. Amoros M., Simoes C.M.O., Girre L., Sauvager F., Cormier M. Synergistic effect of flavons and flavonols against Herpes simplex virus-type 1 in cell culture. Comparison with the antiviral activity of propolis. J. Nat. Prod. 55, 1732-1740, 1992.
31. Nakayama T., Yamada M., Osawa T., Kawakishi S. Suppression of active oxygen-induced cytotoxicity by flavonoids. Biochem. Pharmacol. 45, 265-267, 1993.
32. Walgrave S.E., Warshaw E.M., Glesne L.A. Allergic contact dermatitis from propolis. Dermatitis. 16, 209-215, 2005.
33. Giusti F., Miglietta R., Pepe P., Seidenari S. Sensitization to propolis in 1255 children undergoing patch testing. Contact Dermatitis 51, 255-258, 2004.
34. Hausen B.M., Wollenweber E., Senff H., Post B. Propolis allergy (II). The sensitising properties of 1,1-dimethylallyl caffeic acid ester. Contact Dermatitis 17, 171-177, 1987.
35. Hausen B.M., Wollenweber E. Propolis allergy (III). Sensitization studies with minor constituents. Contact Dermatitis 19, 296-303, 1988.
36. Havsteen B. Flavonoids, a class of natural products of high pharmacological potency. Biochem. Pharmacol. 32, 1141-1148, 1983.
37. Azarpazhooh A., Leake J.L. Systematic review of the association between respiratory diseases and oral health. J. Periodontol. 77, 1465-1482, 2006.
38. Tan T.Q. The appropriate management of pharyngitis in children and adults. Expert Rev. Anti Infect. Ther. 3, 751-756, 2005.
39. Bisno A.L., Gerber M.A., Gwaltrey J.M. et al. Practice guidelines for the diagnosis and management of adults with pharyngitis - a cost-effectiveness analysis. Ann. Intern. Med. 139, 113-122, 2003.
40. Gerber M.A., Randolph M.R., Martin N.J. Community-wide outbreak of Group G streptococcal pharyngitis. Pediatrics 87, 598-603, 1991.
41. Brook I., Gober A. Increased recovery of Moraxella catarrhalis and Haemophilus influenzae in association with group A β-haemolytic streptococci in healthy children and those with pharyngotonsillitis. J. Med. Microbiol. 55, 989-992, 2006.
42. McCullogh M.J., Savage N.W. Oral viral infections and the therapeutic use of antiviral agents in dentistry. Aust. Dent. J. 50 (Suppl 2), S31-5, 2005.
43. Brook I. Microbiology and management of endodontic infections in children. J. Clin. Pediatr. Dent. 28, 1-7, 2003.
44. Block S.L. Causative pathogens, antibiotic resistance and therapeutic considerations in acute otitis media. Ped. Infect. Dis. 16, 449-456, 1997.
45. Rafei K., Lichenstein R. Airway infectious disease emergencies. Pediatr. Clin. North Am. 53, 215-242, 2006.
46. Brook I., Foote P.A., Hausfeld J.N. Frequency of recovery of pathogens causing acute maxillary sinusitis in adults before and after introduction of vaccination of children with the 7-valent pneumococcal vaccine. J. Med. Microbiol. 55, 943-946, 2006.
47. Arroll B. Antibiotics for upper respiratory tract infections: an overview of Cochrane reviews. Resp. Med. 99, 255-261, 2005.
48. Brunton S., Pichichero M. Considerations in the use of antibiotics for streptococcal pharyngitis. J. Fam. Pract. S9-16, 2006.
49. Tewfik T.L., Al Garni M. Tonsillopharyngitis: clinical highlights. J. Otolaryngol. 34 Suppl. 1, 45-49, 2005.
50. Dajani A.S., Taubert K., Ferrieri P. et al. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Pediatrics 96, 748-764, 1995.
51. Lonks J.R., Goldmann D.A. Telithromycin: a ketolide antibiotic for treatment of respiratory tract infections. Clin. Infect. Dis. 40, 1657-1664, 2005.
52. Gagliotti C., Nobilio L., Milandri M., Moro M.L., Emilia-Romagna Antibiotic Resistance Study Group. Macrolide prescriptions and erythromycin resistance of Streptococcus pyogenes. Clin. Infect. Dis. 42, 1153-1156, 2006.
53. Drago L., Ripa S., Zampaloni C, et al. Activity of ceftibuten, cefaclor, azithromycin, clarithromycin, erythromycin and telithromycin against Streptococcus pyogenes clinical isolates with different genotypes and phenotypes. Chemotherapy. 51, 268-271, 2005.
54. Montagnani F., Stolzuoli L., Zanchi A., Cresti S., Cellesi C. Antimicrobial susceptibility of Streptococcus pyogenes and Streptococcus pneumoniae: surveillance from 1993 to 2004 in central Italy. J. Chemother. 18, 389-393, 2006.
55. Grivea I.N., Al-Lahham A., Katopodis G.D., Syrogiannopoulos G.A., Reinert R.R. Resistance to erythromycin and telithromycin in Streptococcus pyogenes isolates obtained between 1999 and 2002 from Greek children with tonsillopharyngitis: phenotypic and genotypic analysis. Antimicrob. Agents Chemother. 50, 256-261, 2006.
56. Tamayo J., Perez-Trallero E., Gomez-Garces J.L., Alos J.I. Spanish Group for the Study of Infection in the Primary Health Care Setting. Resistance to macrolides, clindamycin and telithromycin in Streptococcus pyogenes isolated in Spain during 2004. J. Antimicrob. Chemother. 56, 780-782, 2005.
57. Malhotra-Kumar S, Lammens C, Chapelle S, et al. Macrolide- and telithromycin-resistant Streptococcus pyogenes, Belgium, 1999-2003. Emerg. Infect. Dis. 11, 939-942, 2005.
58. D'Ancona F.P., Alfonsi V., Giannitelli S., et al. Sorveglianza dell'antibiotico resistenza in Italia per gli anni 2003-2004-2005. Not. Ist. Super. Sanità. 19, iii-iv, 2006.
59. De Vecchi E., Nicola L., Zucchetti E., Drago L. In vitro induction of resistance by tissue concentrations of azithromycin, clarithromycin, cefixime and amoxicillin/clavulanate in clinical isolates of Streptococcus pyogenes. J. Chemother. 18, 379-88, 2006.
60. Drago L., De Vecchi E., Nicola L., Legnani D., Prenna M., Ripa S. In vitro selection of resistance to clarithromycin in Streptococcus pneumoniae clinical isolates. J. Chemother. 17, 161-168, 2005.
61. Leclercq R. Will resistance to ketolides develop in Streptococcus pneumoniae? J. Infect. 44 Suppl A, 11-6, 2002.
62. Carsenti-Dellamonica H, Galimand M, Vandenbos F. In vitro selection of mutants of Streptococcus pneumoniae resistant to macrolides and linezolid: relationship with susceptibility to penicillin G or macrolides. J. Antimicrob. Chemother. 56, 633-642, 2005.
63. Drago L., De Vecchi E., Nicola L., Colombo A., Gismondo M.R. Selection of resistance of telithromycin against Haemophilus influenzae, Moraxella catarrhalis and streptococci in comparison with macrolides. J. Antimicrob. Chemother. 54, 542-545, 2004.
64. Clark C., Bozdogan B., Peric M., Dewasse B., Jacobs M.R., Appelbaum P.C. In vitro selection of resistance in Haemophilus influenzae by amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycin. Antimicrob. Agents Chemother. 46, 2956-2962, 2002.
65. Grange J.M., Davey R.W. Antibacterial properties of propolis (bee glue) J. Royal Soc. Med. 83, 159-160, 1990.
66. Park Y.K., Koo M.H., Abreu J.A.S., Ikegaki M., Cury J.A., Rosalen P.L. Antimicrobial activity of propolis on oral microorganisms. Curr. Microbiol. 36, 24-28, 1998.
67. Salomao K., Dantas A.P., Borba C.M., Campos L.C., Machado D.G., Aquino Neto F.R. Chemical composition and microbicidal activity of extracts from Brazilian and Bulgarian propolis. Lett. Appl. Microbiol. 38, 87-92, 2004.
68. Bosio K., Avanzino C., D'Avolio A., Ozino O., Savoia D. In vitro activity of propolis against Streptococcus pyogenes. Lett. Appl. Microbiol. 31, 174-177, 2000.
69. Pepeljnjak S., Kosalec I. Galangin expresses bactericidal activity against multiple-resistant bacteria: MRSA, Enterococcus spp. and Pseudomonas aeruginosa. FEMS Microbiol. Lett. 240, 111-116, 2004.
70. Drago L., Mombelli B., De Vecchi E., Fascina M.C., Tocalli L., Gismondo M.R. In vitro antimicrobial activity of propolis dry extract. J. Chemother. 12, 390-395, 2000.
71. Santos F.A., Bastos E.M.A., Uzeda B., Carvalho M.A.R., Farias E.S.A., Braga F.C. Antibacterial activity of Brazilian propolis and fractions against oral anaerobic bacteria. J. Ethnopharmacol. 80, 1-7, 2002.
72. Fernandes A. Jr., Balestrin E.C., Betoni J.E.C., Orsi R.O., da Cunha M.L.R.S., Montelli A.C. Propolis: anti-Staphylococcus aureus activity and synergism with antimicrobial drugs. Mem Inst. Oswaldo Cruz. 100, 563-566, 2005.
73. Orsi R.O., Sforcin J.M., Funari S.R.C., Fernandes A. Jr., Bankova V. Synergistic effect of propolis and antibiotics on the Salmonella typhi. Braz. J. Microbiol. 37, 108-112, 2006.
74. Nostro A., Cellini L., Di Bartolomeo S., et al. Effects of combining extracts (from Propolis or Zingiber officinale) with clarithromycin on Helicobacter pylori. Phytother. Res. 20, 187-190, 2006.
75. Ito J., Chang F.R., Wang H.K., et al. Anti-AIDS agents. Anti-HIV activity of moronic acid derivatives and the new melliferone-related triterpenoid isolated from Brazilian propolis. J. Nat. Prod. 64, 1278-1281, 2001.
76. Serkedjieva J., Manolova N., Bankova V. Anti-influenza virus effect of some propolis constituents and their analogues (esters of substituted cinnamic acids). J. Nat. Prod. 55, 294-302, 1992.